Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 1 | 2010 | 36 | 0.320 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 1 | 0.230 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 2 | 0.230 |
Why?
|
| Adenoma | 1 | 2005 | 6 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 11 | 0.180 |
Why?
|
| Humans | 13 | 2016 | 5837 | 0.170 |
Why?
|
| Female | 9 | 2016 | 3346 | 0.140 |
Why?
|
| Male | 9 | 2016 | 3399 | 0.140 |
Why?
|
| Aged | 7 | 2014 | 1860 | 0.130 |
Why?
|
| Adult | 6 | 2016 | 1670 | 0.130 |
Why?
|
| Cryosurgery | 2 | 2013 | 4 | 0.120 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 3 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 15 | 0.120 |
Why?
|
| Middle Aged | 6 | 2014 | 1775 | 0.120 |
Why?
|
| Scoliosis | 1 | 2016 | 7 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 10 | 0.120 |
Why?
|
| Retrospective Studies | 4 | 2016 | 584 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2016 | 59 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2015 | 8 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2015 | 19 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2015 | 16 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 51 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2015 | 139 | 0.100 |
Why?
|
| Dietary Proteins | 1 | 2014 | 12 | 0.100 |
Why?
|
| Muscles | 1 | 2014 | 40 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2013 | 7 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 2 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 24 | 0.100 |
Why?
|
| Iodine Radioisotopes | 1 | 2012 | 3 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2012 | 5 | 0.100 |
Why?
|
| Optic Disk | 1 | 2012 | 1 | 0.090 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 1 | 0.090 |
Why?
|
| Glaucoma | 1 | 2012 | 2 | 0.090 |
Why?
|
| Nerve Fibers | 1 | 2012 | 3 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 3 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 4 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2013 | 601 | 0.090 |
Why?
|
| Algorithms | 1 | 2012 | 82 | 0.090 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Furans | 1 | 2011 | 2 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 5 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 2 | 0.080 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2010 | 2 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 78 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 109 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 72 | 0.080 |
Why?
|
| Adolescent | 2 | 2016 | 488 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 4 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 1 | 0.070 |
Why?
|
| ras Proteins | 1 | 2009 | 2 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 13 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 9 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 27 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 37 | 0.070 |
Why?
|
| Mutation | 1 | 2009 | 101 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 87 | 0.070 |
Why?
|
| Brain | 1 | 2009 | 331 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 1034 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 33 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 25 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 28 | 0.060 |
Why?
|
| Hypophysectomy | 1 | 2005 | 2 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 409 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 5 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 207 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2015 | 9 | 0.050 |
Why?
|
| Aging | 1 | 2006 | 352 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 125 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 71 | 0.050 |
Why?
|
| Disease Progression | 2 | 2012 | 157 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 29 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2016 | 23 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 363 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 2 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 3 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 14 | 0.030 |
Why?
|
| Child | 1 | 2016 | 339 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 35 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 31 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 10 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 65 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 17 | 0.030 |
Why?
|
| Young Adult | 1 | 2016 | 421 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 1 | 0.030 |
Why?
|
| India | 1 | 2014 | 3 | 0.030 |
Why?
|
| Arm | 1 | 2014 | 7 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 7 | 0.030 |
Why?
|
| China | 1 | 2014 | 13 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 18 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 12 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 48 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 6 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 35 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 111 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 465 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 63 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 167 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 23 | 0.020 |
Why?
|
| Palliative Care | 1 | 2012 | 16 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 45 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 19 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 34 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 374 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 16 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 5 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 24 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 17 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 51 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 30 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 1349 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 10 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 8 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 21 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 109 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 2 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 5 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 6 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 13 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 16 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 11 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 41 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 37 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 25 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 4 | 0.020 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 2 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 5 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2009 | 3 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 4 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 36 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 51 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 26 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 52 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 27 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 37 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 60 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 74 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 499 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 138 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 141 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 28 | 0.010 |
Why?
|
| Dementia | 1 | 2006 | 127 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 134 | 0.010 |
Why?
|